January 3, 2025 - 05:53

On Thursday, Carpenter Technology stock received an upgrade in its IBD SmartSelect Composite Rating, moving from a score of 94 to an impressive 96. This upgrade reflects the company's strong performance and market position, highlighting its potential for growth and stability in a competitive industry.
The IBD SmartSelect Composite Rating is a comprehensive metric that considers various factors, including price performance, earnings growth, and overall market conditions. A rating of 96 places Carpenter Technology in a favorable position compared to its peers, indicating that it is one of the top-performing stocks in the market.
Investors often look for stocks with high ratings as they tend to outperform in the long run. This latest upgrade could attract more attention from investors seeking reliable opportunities, especially in the current economic climate. As Carpenter Technology continues to navigate the challenges of the market, this rating upgrade may bolster confidence among stakeholders and pave the way for further advancements in the company's strategic goals.
August 8, 2026 - 01:15
19th century real estate agents used ‘peepshow’ technology to sell glitzy mansionBefore Zillow, before glossy real estate brochures, there was the cosmorama. In the 1840s, wealthy home sellers and developers in Europe and America turned to these handheld viewing boxes to show...
August 7, 2026 - 06:56
AI used to create viruses not found in nature for first timeA team of researchers in the United States has announced the creation of 16 new viruses that do not exist in nature, marking the first time artificial intelligence has been used to design such...
August 6, 2026 - 19:49
MatSing Details Manufacturing Technology to Improve Satellite Antenna PerformanceMatSing has introduced a proprietary manufacturing process designed to boost the capabilities of multibeam and wideband antennas used in satellite communications. The company says the new technique...
August 6, 2026 - 03:31
FDA approves Moderna’s mRNA flu vaccine, the first to use the technologyThe U.S. Food and Drug Administration has given the green light to Moderna`s new influenza vaccine, marking the first time a flu shot built on messenger RNA technology has been licensed. The...